Generic Prolia available in Canada??
Osteoporosis treatments like Prolia are critical for patients at risk of fractures due to bone density loss. Prolia (denosumab) was approved by the U.S. Food and Drug Administration (FDA) in June 2010 for the treatment of postmenopausal women with osteoporosis at high risk for fractures. Since then, its use has expanded to include men with osteoporosis, patients undergoing certain cancer treatments, and individuals with glucocorticoid-induced osteoporosis.
Health Canada has recently approved Jubbonti for the same indications as Prolia. Jubbonti was approved as the first biosimilar to Prolia. However, Jubbonti is not considered interchangeable with Prolia in Canada. This means pharmacists would need authorization from the physician to substitute Jubbonti for Prolia. Both medications have the same dosage form, route of administration, and dosing schedule. Jubbonti and Prolia are administered as a subcutaneous injection every six months. Both medicines reduce the risk of fractures and increase bone mass. However, do they share the same efficacy?
Both Prolia and Jubbonti are highly effective for treating osteoporosis. Jubbonti has demonstrated clinical equivalence to Prolia regarding safety, effectiveness, and pharmacokinetics. Jubbonti is a relatively new treatment and the FDA has approved it as a biosimilar to Prolia.
Biosimilars like Jubbonti, produced by Sandoz, are introduced to offer cheaper options to the reference biological. In this case, the reference biological is Prolia. Currently, prices for Prolia hover around $1800-$2000 in the United States. Jubbonti’s pricing is around $500 per dose at your trusted Canadian online pharmacy. That translates to about $3000 in savings annually using Jubbonti from Canada!
So Jubbonti is not considered the generic of Prolia, but rather biosimilar. The two medications are clinically equivalent and are indicated to treat the same conditions. However, in Canada, patients will need a prescription written for Jubbonti. In the US, interchangeability simplifies access to treatment.
Patients considering these treatments should consult their healthcare provider to determine which option is best for their medical and financial situation. Patients may also contact our Canadian pharmacy to speak with a pharmacist about this product or obtain current pricing information.
For inquiries about prescription medications, contact our team at Jason’s CanadaDrugstore.com by calling 1-800-226 3784 (CAN-DRUG) for assistance from our patient representatives or a licensed Canadian pharmacist.
This article provides medical information to help understand a condition or treatment plan but is not a diagnosis or treatment recommendation. Contact your doctor if you have concerns or symptoms. In case of emergency, call 911.
Leave a Reply